OptimizeRx’s AI-Driven Therapy Initiation and Persistence Platform Wins 2022 BIG Innovation Award
JANUARY 18, 2022
OptimizeRx’s AI-Driven Therapy Initiation and Persistence Platform
The Business Intelligence Group’s annual BIG Innovation Awards program recognizes organizations, products, and people that are bringing new ideas to life in innovative ways. OptimizeRx’s AI-Driven Therapy Initiation and Persistence platform empowers pharmaceutical manufacturers to easily implement and measure tech-enabled awareness, market access, and adherence programs.
“Innovation is driving growth in the global economy,” said Maria Jimenez, chief operating officer of the Business Intelligence Group. “We are thrilled to be honoring OptimizeRx’s AI-Driven Therapy Initiation and Persistence platform as they are one of the organizations leading this charge and helping humanity progress.”
